Navigation Links
Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity

CHICAGO Findings presented today at the American Society of Clinical Oncology Annual Meeting by Eva Galanis, M.D., a Mayo Clinic oncologist, reveals that a novel application of the drug vorinostat shows activity in patients with recurrent glioblastoma multiforme. The study was conducted by North Central Cancer Treatment Group (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn. Eva is the lead investigator of the study.

Glioblastoma multiforme is a lethal primary brain tumor. The average survival of glioblastoma patients is 12-16 months. These tumors spread quickly to other parts of the brain, and because of this are difficult to treat and often recur. When the tumor recurs, treatment options are limited, and patients survive for an average of three to four months.

"Existing treatment interventions have minimal impact on the outcome of recurrent glioblastoma multiforme patients," Dr. Galanis says. "Using vorinostat to treat glioblastoma multiforme patients who have relapsed following surgery, radiation and chemotherapy, we found that 15 percent of the patients had no tumor recurrence for six months or longer following treatment initiation. The median overall survival of the patients enrolled on the trial was 5.7 months -- similar patient populations enrolled in prior NCCTG trials had a median overall survival of between 4 and 4.4 months."

This study was the first application of vorinostat in targeting brain cancer. Vorinostat is approved by the U.S. Food and Drug Administration (FDA) for the treatment of cutaneous T cell lymphoma in patients who have failed two or more systemic therapies.

An additional group of patients in this study was treated with vorinostat prior to surgery, and a gene and protein analysis of their resected tumors was performed. This analysis confirmed increase in histone acetylation and showed gene changes indicating that vorinostat reaches the glioblastoma tumors and interferes
'"/>




Page: 1 2

Related medicine news :

1. Estrogen Does Not Prevent Recurrent Strokes
2. Radiation Therapy An Effective Solution For Recurrent Prostate Cancer
3. Prevention Of Recurrent Leg Ulcers
4. Measuring Urinary Protein Helps In Detecting Recurrent Bladder Cancer
5. Sertraline Can Prevent Recurrent Depressive Episodes In Diabetics
6. Angola Warned of Recurrent Cholera Outbreaks
7. Gemzar the New Drug for Recurrent Ovarian Cancer
8. Recurrent Stroke Risk is Minimized by Statin
9. Blood Markers Predict Risk for Recurrent Stroke and Mortality
10. Targeted Compound Helps Recurrent Prostate Cancer Patients
11. Ancient Indian Herb May Prove Cure For Recurrent UTI
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Recurrent Gliomas Vorinostat Shows Anti cancer Activity

(Date:7/31/2015)... ... ... ZH Healthcare announces a new cloud based service delivering Health IT as ... Service (HITaaS) is a Healthcare dedicated cloud based service that sits over infrastructure as ... all aspects of infrastructure, security, runtime, middleware, OS, virtualization, Servers, storage, contracts, and ...
(Date:7/31/2015)... ... 31, 2015 , ... New Energy Works Timberframers invites the public to join ... 15th, 2015 from 9am – 12pm. Timber frame raisings are special, celebrating ... community as the culmination of months of effort, planning, fundraising, and dreaming takes shape. ...
(Date:7/31/2015)... ... , ... “ Crack’em ” was featured on NewsWatch as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... Cooking can be a very messy experience, especially when cracking eggs. Cracking an egg ...
(Date:7/31/2015)... ... ... Seals Southern Georgia’s Heels & Wheels Duathlon & Triathlon will be held Saturday, August 22nd ... duathlon is a 2 mile run, 13 mile bike ride, and a 3 mile run. ... and a 3 mile run. Heels & Wheels is sponsored by Mayo Clinic System ...
(Date:7/31/2015)... ... July 31, 2015 , ... David Gilpin, ... website to inform potential Nashville area sinus sufferers about the benefits ... to determine if someone is a good candidate for Balloon Sinuplasty. The questionnaire ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Make Less Mess while Cooking with Crack’em 2Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 3
... of Pennsylvania School of Medicine and other study sites ... non-invasive technique that excites neurons in the brain via ... safe and effective, non-drug treatment with minimal side effects ... treatment options without benefit. , This study ...
... generates green pods while a variant of that gene ... helped Gregor Mendel, the 19th century Austrian priest and ... are focused on the strange ability of some genes ... ways. , In order to better understand this phenomenon ...
... researchers have identified structural damage to the lungs caused ... the study, conducted by researchers at the University of ... Hospital of Philadelphia in Pennsylvania, were presented today at ... America (RSNA). , Its long been hypothesized that prolonged ...
... of Australias leading medical,research institutes, unveiled a powerful ... cutting edge in medical technology and microscopy, the ... scientists at the Centenary Institute,unprecedented access to the ... and molecular,level., The Centenary Institute is equally excited ...
... CARLSBAD, Calif., Nov. 26 Visage Imaging, a,wholly ... MRCY ),announced an agreement with Siemens Medical ... solutions to hospitals and imaging,centers worldwide., Siemens ... into its SIENET Magic product line. This unique ...
... Ohio, Nov. 26 Understand how improving ... That,s the message behind,the new book "REM ... by Timothy J. Walter, M.D., a sleep ... (Lotus Magnus, August,2007, ISBN-13: 978-1604022377, $19.95) integrates ...
Cached Medicine News:Health News:Penn research shows transcranial magnetic stimulation effective in treating major depression 2Health News:Flip-flopping gene expression can be advantageous 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2Health News:World class technology and talent battle cancer at the Centenary Institute 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 3Health News:Understand How Sleep Impacts Learning and Memory 2
(Date:7/30/2015)... , July 30, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Biosensors Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) Explore ...
(Date:7/30/2015)...   Gaumard® Scientific Company today announced ... first operating system to support an entire family ... Gaumard users. UNI® version 2.27.21.0 adds enhanced functionality ... as well as improvements to laboratory functions, patient ... as EtCO 2 .  First ...
(Date:7/30/2015)... 2015   Sentrian , the Remote Patient ... recently received confirmation from the Food & Drug ... solution meets the definition of a "medical device" ... Discretion." The designation identifies medical ... regulatory requirements at this time" and clears the ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 2Gaumard's Latest UNI Operating System Update Adds Performance and New Functionality 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
... Effectiveness of Autologous Therapy, DUSSELDORF, Germany, ... two-year,representative study of knee osteoarthritis, published in ... safety and effectiveness of Orthokine therapy, in ... blood are,injected into the arthritic joint., ...
... New Therapeutic Platform in Patients with Cystoid Macular ... ... Aug. 5 Icon Bioscience, Inc., (IBI),a privately held ophthalmic pharmaceutical ... clinical trial to assess the,safety and efficacy of its lead product, ...
Cached Medicine Technology:Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 2
The Leica M500 OH3 is an advanced surgical microscope used by neurosurgeons. It is a smart system combining the best optical performance available on the market with an innovative and unique stand....
Surgical Loupes...
... MAGNETOM Allegra is the ultimate brain ... been optimized for best image quality ... all in a highly compact design. ... diagnosing stroke, epilepsy, tumor and multiple ...
Signa Profile is built on the Signa foundation to deliver speed & image quality....
Medicine Products: